ABSTRACT-Objective.
Direct intravesical instillation of antibiotics for bladder infections
offers some advantages over oral therapy The drug is brought directly to the site of action, and the impermeability of the bladder minimizes systemic effects. Bypassing the gastrointestinal tract avoids nausea, diarrhea, and colonic superinfection associated with some oral agents. There is concern, however, that absorption of intravesical antibiotics could be increased in an infected bladder with an inflamed epithelium. This is also of concern in patients with vesicoureteral reflux, prior enterocystoplasty, or renal transplantation.
Submitted: September 28, 1993, accepted (with revisions): December 3, 1993 The aminoglycoside gentamicin was selected for investigation as an intravesical agent. We had used it empirically for antimicrobial prophylaxis and for treatment of bacilluria in adult spinal-cord-injured patients undergoing clean intermittent catheterization (CIC). A series of experiments were then constructed using rat and canine models to investigate the absorption of intravesical gentamicin in the presence of an active urinary infection and vesicoureteral reflux. In vitro testing was done to determine the effects of pH and temperature as well as duration of shelf storage on antibiotic potency. Finally the absorption of intravesical gentamicin in patients was measured in a variety of clinical situations including bladder augmentation, vesicoureteral reflux, and renal transplantation.
MATERIAL AND METHODS

RAT INFECTION MODEL
An infected fulgurated rat bladder model was created using a previously described technique.' Seven adult rats (body weight, 125-250 g) were anesthetized with intraperitoneal pentobarbital (45 mg/kg). The lower abdomen was shaved and cleaned with povidone-iodine.
A midline incision was made to expose the bladder. A 27-gauge hypodermic needle transmurally drained and collapsed the bladder. The dome of the bladder was opened with a scalpel. The posterior bladder wall epithelium was fulgurated with needle tip electrocautery The cystotomy was closed with a single continuous 5-O chromic suture. A clinical isolate of Escherichia coli from the hospital microbiology laboratory was the infecting agent. One cc of a transport media broth from a twenty-four-hour E. coli urine culture documented to have one million colonies per milliliter was injected into the bladder. The abdomen was closed with a single 2-O chromic suture. After one week the rats were again anesthetized, prepped, and the incision was reopened to expose the bladder. Urine was aspirated from the bladder through a needle and was cultured. All specimens showed active infection (> 1 ,OOO,OOO colonies/ml).
One cc of a gentamicin sulfate (GS) solution (480 mg GS/l L 0.9% NaCI) was injected back down the needle into the intact bladder. Venous blood was drawn from the inferior vena cava thirty minutes after intravesical instillation and gentamicin levels were determined using a standard assay CANINE MODEL A dog model was created to determine the effect of elevated bladder pressures and vesicoureteral reflux on absorption of intravesical gentamicin. Fluoroscopic cystograms were performed on six adult mongrel female dogs (weight, 23 to 30.5 kg) under halothane anesthesia using 60% Hypaque meglumine.
Two of the animals (#5 and #l) demonstrated natural bilateral vesicoureteral reflux during gravity filling with contrast media. The other four animals were prepped and underwent a low midline incision to expose the bladder. The bladder was opened and a generous ureteral meatotomy and partial division of the intravesical sheath were performed. The free edges were sewn back with fine absorbable suture. The bladder was closed with two layers of absorbable sutures. Repeat fluoroscopic cystograms showed bilateral vesicoureteral reflux in all six dogs at bladder pressures of 7 to 15 cm H,O. A GS solution (240 mg GS/l L 0.9% NaCl) was then infused the same day through a urethral catheter. The retention balloon had been filled with 5 cc sterile NaCl and the catheter pulled down to occlude the vesical outlet. The GS solution was forcefully infused until a pressure of 40 cm H,O was reached. Serum for gentamicin levels was taken at zero and thirty minutes after the maximum pressure had been reached. Serum creatinine levels were drawn at zero minutes and three days postinfusion.
IN VITRO MODEL
To determine the effect of storage conditions such as pH, age, and temperature a set of GS solutions was prepared (480 mg GS/l L 0.9% NaCl). The bottles were divided into two groups. The first group was alkalinized to a pH of 8 with 100 mEq NaHCO,. The second group was left unalkalinized with a pH of 5. Within each group the bottles were again divided so that half were stored in a household food refrigerator (2-7°C) while the others were kept at room temperature (15-25"(Z). The bottles within each pH and temperature group were then separately aged two months, one month, and two weeks. A total of twelve bottles of GS solution representing the different pH, temperature, and shelf age combinations were thus made. Comparisons of potency were made between the aged and two fresh solutions of gentamicin sulfate (with and without NaHCO,) using a modified disk susceptibility technique.2 Filter paper disks (6.35 mm diameter; Schleicher & Schnell, Keene, NH) were loaded with 20 l.tL aliquots pipetted from each bottle. Mueller Hinton agar plates (150 mm size) were seeded with samples of genitourinary pathogens gathered from positive urine cultures found by the hospital clinical microbiology laboratory. Isolates of E. coli, Pseudomonas aeruginosa, Enterobacter cloacae, Streptococcus fecalis, Proteus mirabilis, Klebsiella pneumoniae, and coagulase-positive Staphylococcus were resuspended to a concentration that yielded a BaSO, McFarland standard of 0.06 absorbance units as measured by a spectrophotometer (Bausch & Lomb, Rochester, NY). These bacterial suspensions were then plated on the agar plates as a series of nonoverlapping concentric rings. The disks loaded with the GS solutions along with a commercially prepared control disk of GS (10 pg/zO l..tL, yielding an effective disk concentration of 500 pg/mL or 500 mg/L) were then placed on the plates with ample separation between each disk to prevent cross-disk interference. The plates were then inverted to prevent condensation on the agar surface and incubated at 35°C for eighteen hours. Three measurements of the diameters of the zones of inhibition were made using graduated calipers and the average was recorded. The results were then analyzed using a computer software package.
HUMAN STUDIES
Ten children who perform CIC for neurogenic bladders were placed on bladder instillation with GS (480 mg GS/l L 0.9% NS). Four boys and six girls were aged from one to eighteen years. Their conditions represented a variety of diagnoses with the most common being myelomeningocele.
All patients demonstrated bacteriuria on urinalysis. Three patients had vesicoureteral reflux and three had undergone augmentation enterocystoplasty. Two patients subsequently had renal transplantation while on GS irrigation. Each patient instilled 30 to 60 mL of GS solution twice a day at the conclusion of a regularly scheduled catheterization.
The GS solution was left to dwell after instillation.
All had serum gentamicin levels drawn thirty minutes after instillation and had creatinine levels monitored during therapy Cultures were obtained at the start of therapy and after one week of treatment.
RESULTS
RAT INFECTION MODEL.
Four animals had no measurable serum levels of gentamicin (Table I) . Absorption of gentamicin was noted in three of seven rats (43%), but absorbed serum levels were all in the low-nontoxic range for the laboratory (4 to 12 pg/mL).
CANINE MODEL Serum levels of gentamicin were not detectable at time zero minutes or after thirty minutes of maximum intravesical pressure (Table II) . Serum creatinine levels were not altered.
IN VITRO MODEL
The S. fecalis plate showed small inhibition diameters (5 12 mm) consistent with drug resistance in all disks3 This was an expected finding because S. fecalis is known to be resistant to aminoglycosides.3,4 On all the other plates, all disks had inhibition diameters (2 15 mm) consistent with marked drug sensitivity.3 Repeated analyses of variance were performed and did not find any significant differences between the size of the zone diameters of the disks on each plate (P < 0.01, Table III ). This implied that each solution on each plate was equally effective regardless of storage condition. The unalkalinized solutions were as potent as those treated with NaHCO,. Room temperature and aging up to two months had no effect on potency. HUMAN 
DATA
None of the patients at thirty minutes after installation had detectable serum levels of gentamicin sulfate and serum creatinine levels remained unchanged (Table IV) . None of the patients encountered any difficulty with the instillation. There were no adverse reactions. Urine cultures grew out > 100,000 colonies/ml of E. coli in 3 patients prior to treatment. None of the children had development of fungal infections or bladder colonization with organisms resistant to gentamicin. All had negative urine cultures after one week of therapy COMMENT Intravesical medications have a long history of use for superficial transitional cell carcinoma of the bladder. High concentrations of antineoplastic agents can be achieved with minimal absorption; hence, few systemic side effects occur. Intravesical Human gentamicin levels instillation of antibiotics is a similar form of brachytherapy that offers several distinct advantages over oral and parenteral antimicrobial therapy Gastrointestinal upset or diarrhea associated with some oral preparations is avoided. The body's normal colonic flora is much less likely to be disturbed, thereby lessening the risk of pseudomembranous colitis or fungal superinfection.
The principal disadvantages have been concerns about effectiveness, bladder epithelial irritation, toxic absorption, and the inconvenience of having to pass a catheter. These perceptions are reflected in many of the early studies of instilled antibiotics that focused on individuals who were irrigated through indwelling catheters as a prophylactic measure against perioperative cystitis.5-7 Ball et al.* studied the effects of chlorhexidine in men after transurethral surgery Chamberlain and Needham investigated polymixin B, bacitracin, and neo-534 mycin irrigations in women who underwent hysterectomy. Giannoni et ~1.~ evaluated 300 men who were irrigated with povidone-iodine after transurethral resection of the prostate. These studies and others found fewer episodes of symptomatic bacteriuria while patients were on irrigation, but also confirmed suspicions about possible limitations of the technique. 5-10 Certain agents such as acetic acid irritated the bladder epithelium and caused ulcers. lo Others such as chlorhexidine were poorly effective against common iatrogenic pathogens such as Pseudomonas."
The value of intravesical therapy compared to simple closed drainage or conventionally administered medications was questioned. 12 The development and popularization of CIC as a reservoir-emptying technique renewed the interest in intravesical medications.t3
Clean intermittent catheterization permitted new options in the management of neurogenic bladders, urologic cancers, and urinary tract reconstruction with bowel. Procedures and therapies that had poor clinical results prior to CIC because of inadequate urine drainage became practical. The utility of intravesical medications has likewise increased. Greenfield and Feral4 showed that intravesical oxybutynin chloride can be used safely to manage hyperreflexic hypertonic bladders in children who could not otherwise tolerate oral medications at an effective dose. Massad and colleaguest5 demonstrated a lack of significant systemic side effects despite detectabie levels of absorbed intravesical oxybutynin higher than those found with orally administered drug. This observation was interpreted as suggesting that a hepatic metabolite generated by passage down the gastrointestinal tract may be responsible for the anticholinergic side effects. Other agents such as calcium channel blockers and tricyclic antidepressants, which are usually administered orally, also are effective intravesically.16 One of us (E.J.M.) has empirically used gentamicin sulfate for prophylaxis and treatment of bacterial cystitis for ten years in adult spinal-cord-injured patients on CIC who periodically experienced bacterial cystitis if not kept on oral antibiotics, and sometimes in spite of medication. The infections might be asymptomatic or present with cloudy malodorous urine or new-onset urinary leakage. None would be febrile, but all would have bacteriuria and all would have positive urine cultures. When GS instillation was begun, the urine would clear, cultures would become negative, and patients could stop taking oral agents. About 10 percent of all adult spinal-cord-injured patients evaluated by the authors utilize intravesical GS in this manner.l' To determine what factors may affect the safe and effective usage of intravesical GS, the studies presented here were conducted.
Gentamicin sulfate is an ideal intravesical antibiotic. It is a proven bactericide against most genitourinary pathogens (especially Pseudomonas species and other gram-negative organisms). First isolated as a derivative of Micromonospora purpurea in 1963, gentamicin has been widely used intravenously. I8 Commercially synthesized as gentamicin sulfate, it is highly cationic and does not easily cross lipid membranes. When administered orally, it is poorly absorbed, although absorption has been noted when exposed to serosal surfaces, burns, and wounds during lavage or irrigation.18 Our findings in the rat model suggest that severe inflammation does increase absorption from the bladder. The canine and human data suggest that high intravesical pressure and vesicoureteral reflux without inflammation do not themselves predispose to increased absorption. However, although significant levels of absorbed gentamicin did not develop in any patient, further studies are needed to determine if monitoring of serum gentamicin levels is necessary in patients with bladder augmentation, renal failure, or those taking immunosuppressive drugs.
The effects of storage conditions are important to the usefulness of GS as an intravesical agent. For outpatients the convenience and economy of being able to prepare liter quantities of irrigation solution and store at room temperature is appealing. It is known that GS is more potent in an alkaline environment.
Increased acidity can increase the minimal concentration needed to inhibit the growth of gram-negative bacilli eight to thirtytwo-fold."
Prolonged exposure to higher temperatures (> 20"(Z), oxygen, and plastics has been identified as a factor that can lead to a loss of antimicrobial activity. 2o-22 The in vitro data demonstrate that GS can be safely stored without refrigeration or alkalinization and remains potent for up to two months. lntravesical instillation of GS is safe and effective. For patients who perform CIC it should be considered as a route of prophylaxis against recurrent simple bacterial cystitis. It obviates the need for oral agents and their attendant risks. This evaluation of GS has established the criteria by which other potential intravesical antimicrobial agents can be judged: it has a low risk of absorption across a spectrum of clinical situations, it is highly effective against likely pathogens, and it demonstrates prolonged stability without special storage conditions.
